Bromodomain inhibitor-9
Modify Date: 2024-01-17 07:42:15
Bromodomain inhibitor-9 structure
|
Common Name | Bromodomain inhibitor-9 | ||
|---|---|---|---|---|
| CAS Number | 1870849-34-5 | Molecular Weight | 484.57 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H28N4O5S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Bromodomain inhibitor-9Bromodomain inhibitor-9 is a Bromodomains inhibitor that selectively inhibits BRD4-1 (Kd: 12 nM). Bromodomain inhibitor-9 can be used in the research of diseases or conditions associated with systemic or tissue inflammation, lipid metabolism, fibrosis or chronic autoimmune diseases[1]. |
| Name | Bromodomain inhibitor-9 |
|---|
| Description | Bromodomain inhibitor-9 is a Bromodomains inhibitor that selectively inhibits BRD4-1 (Kd: 12 nM). Bromodomain inhibitor-9 can be used in the research of diseases or conditions associated with systemic or tissue inflammation, lipid metabolism, fibrosis or chronic autoimmune diseases[1]. |
|---|---|
| Related Catalog | |
| Target |
BRD4-1:12 nM (Kd) BRD4-2:5600 nM (Kd) |
| In Vitro | Bromodomain inhibitor-9 (Compound 99, 1 h) inhibits LPS induced cytokines (IL12P40) release in PBMCs, with an IC50 value of 400 nM[1]. |
| References |
| Molecular Formula | C24H28N4O5S |
|---|---|
| Molecular Weight | 484.57 |